Direct Action

5 02, 2016

FGEP and other Latin American organizations requested a Thematic Hearing at the Inter-American Commission on Human Rights

2018-02-05T10:36:13-03:00viernes, 5 febrero, 2016|Advocacy, Direct Action, Hepatitis C, HIV, Medicines, Public Health, RedLAM|

Por: Julia Varela   GEP Foundation (FGEP), along with more than 20 other civil society organizations from different countries in Latin America committed to defending the right to health, requested last January 18th a Thematic Hearing at the Inter-American Commission on Human Rights (IACHR) on the issue of lack of access to medicines. The request

17 12, 2015

FGEP continues defense of public health in Argentina against the abuse of the patent system by multinational pharmaceutical companies

2015-12-17T03:50:58-03:00jueves, 17 diciembre, 2015|Access to Medicines, Argentina, Direct Action, Health Safeguards, HIV, Intellectual Property, Kaletra, Patent opposition, Sofosbuvir|

BUENOS AIRES, December 15th 2015 - Fundación Grupo Efecto Positivo (FGEP), an organization whose work is focused on guaranteeing access to essential medicines for HIV and Hepatitis C in Argentina and Latin America, announced in a press conference on November 30th two new key actions to defend public health policies. Dr. Daniel Gollán, Argentina’s Minister

27 08, 2015

People living with HepC denounced high prices of the pharmaceutical industry

2015-11-04T20:18:54-03:00jueves, 27 agosto, 2015|Direct Action, Hepatitis C, Intellectual Property, Patent opposition, Public Health|

Buenos Aires, August 27th 2015 - Members of Grupo Efecto Positivo Foundation (FGEP) accompanied by other civil society organizations and representatives held a direct action during the 2015 Hepatitis International Symposium organized by Fundación Huesped. The action aimed to denounce monopolies and high prices of drugs to treat hepatitis C and took place during the presentation of Dr.

Ir a Arriba